Sertaconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis
Phase 3
Completed
- Conditions
- Seborrheic dermatitis.Seborrheic dermatitis
- Registration Number
- IRCT201310185605N2
- Lead Sponsor
- Tabriz university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Sixty patients with seborrheic dermatitis (SD) were studied.
Patients who had taken oral corticosteroids; retinoids; antihistamines; or immune-modulating drugs within 28 days before study entery were excluded.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Seborrheic index. Timepoint: 2 weeks. Method of measurement: Clinical assesment.
- Secondary Outcome Measures
Name Time Method